Zhang SL, Yi XF, Huang LT, Sun L, et al. Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials. BMC Cancer 2023;23:719.
PMID: 37528390